Abiopharma

🔍 RUSSO PATRICIA F (Director)

Company: Hewlett Packard Enterprise Co (HPE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | shares_owned_after: 15,318.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By Merrill Lynch | shares_owned_after: 366,413.49 | Footnotes: F1
• Acquired 8,750 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,750.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F4, F4

Footnotes:

• F1: The reporting person elected to defer the receipt of common stock until the termination of her service as a member of the Issuer's Board of Directors.
• F2: The number of shares in column 5 includes 1,571.1379 vested restricted stock unit ("RSU") dividend equivalent rights at $27.93 per RSU credited to the reporting person's account on 04/23/26.
• F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F4: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock. The reporting person elected to defer the receipt of common stock until the termination of her service as a member of the Issuer's Board of Directors.